BIS vs. FFTY
BIS (ProShares UltraShort Nasdaq Biotechnology) and FFTY (CapForce IBD 50 ETF) are both exchange-traded funds - BIS is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (-200%), while FFTY is a Mid Cap Growth Equities fund tracking the IBD 50 Index. Both are passively managed. Over the past 10 years, BIS returned -24.02%/yr vs 5.57%/yr for FFTY. Their -0.59 correlation means they have often moved in opposite directions in the past. BIS charges 0.95%/yr vs 0.80%/yr for FFTY.
Performance
BIS vs. FFTY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIS achieves a -24.85% return, which is significantly lower than FFTY's 6.26% return. Over the past 10 years, BIS has underperformed FFTY with an annualized return of -24.02%, while FFTY has yielded a comparatively higher 5.57% annualized return.
BIS
- 1D
- 3.65%
- 1M
- 9.65%
- 6M
- -20.75%
- YTD
- -24.85%
- 1Y
- -53.59%
- 3Y*
- -27.87%
- 5Y*
- -15.63%
- 10Y*
- -24.02%
- ALL TIME*
- -32.48%
FFTY
- 1D
- -0.91%
- 1M
- -9.03%
- 6M
- 3.47%
- YTD
- 6.26%
- 1Y
- 13.28%
- 3Y*
- 13.48%
- 5Y*
- -2.78%
- 10Y*
- 5.57%
- ALL TIME*
- 4.04%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $67.10K | $102.51K | $113.13K | |
| $863.41K | $1.19M | $1.59M |
BIS vs. FFTY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | -24.85% | -45.95% | 4.79% | -6.54% | -2.14% | -14.74% | -56.01% | -41.01% | 5.14% | -36.98% |
FFTY CapForce IBD 50 ETF | 6.26% | 23.38% | 18.36% | 12.40% | -51.08% | 11.92% | 18.20% | 25.74% | -16.76% | 37.62% |
Correlation
The correlation between BIS and FFTY is -0.43, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.43 |
Correlation (3Y) Balances recent behavior with more history. | -0.47 |
Correlation (5Y) Shows whether the relationship held over a longer period. | -0.53 |
Correlation (10Y) Provides a long-term view across more market conditions. | -0.58 |
Correlation (All Time) Calculated using the full available price history since Apr 9, 2015 | -0.59 |
The correlation between BIS and FFTY shifts across timeframes, from -0.59 (all time) to -0.43 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIS vs. FFTY — Risk / Return Rank
BIS
FFTY
BIS vs. FFTY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and CapForce IBD 50 ETF (FFTY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIS | FFTY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.59 | ||
| Sortino ratioReturn per unit of downside risk | -2.80 | ||
| Omega ratioGain probability vs. loss probability | 0.76 | 1.07 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | -0.91 | 0.41 | -1.32 |
| Martin ratioReturn relative to average drawdown | -1.38 | 1.00 | -2.38 |
Loading charts...
Drawdowns
BIS vs. FFTY - Drawdown Comparison
The maximum BIS drawdown since its inception was -99.89%, which is greater than FFTY's maximum drawdown of -59.46%. Use the drawdown chart below to compare losses from any high point for BIS and FFTY.
Loading charts...
Drawdown Indicators
| BIS | FFTY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.89% | -59.46% | -40.43% |
Max Drawdown (1Y)Largest decline over 1 year | -59.49% | -23.29% | -36.20% |
Max Drawdown (3Y)Largest decline over 3 years | -73.96% | -29.60% | -44.36% |
Max Drawdown (5Y)Largest decline over 5 years | -80.19% | -59.46% | -20.73% |
Max Drawdown (10Y)Largest decline over 10 years | -95.82% | -59.46% | -36.36% |
Current DrawdownCurrent decline from peak | -99.88% | -25.10% | -74.78% |
Average DrawdownAverage peak-to-trough decline | -90.11% | -22.32% | -67.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.26% | 9.51% | +29.75% |
Volatility
BIS vs. FFTY - Volatility Comparison
ProShares UltraShort Nasdaq Biotechnology (BIS) has a higher volatility of 12.40% compared to CapForce IBD 50 ETF (FFTY) at 8.45%. This indicates that BIS's price experiences larger fluctuations and is considered to be riskier than FFTY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIS | FFTY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.40% | 8.45% | +3.95% |
Volatility (6M)Calculated over the trailing 6-month period | 31.89% | 29.16% | +2.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.71% | 36.53% | +4.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.93% | 29.75% | +14.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.15% | 27.79% | +18.36% |
BIS vs. FFTY - Expense Ratio Comparison
BIS has a 0.95% expense ratio, which is higher than FFTY's 0.80% expense ratio.
Dividends
BIS vs. FFTY - Dividend Comparison
BIS's dividend yield for the trailing twelve months is around 5.61%, more than FFTY's 1.27% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 5.61% | 5.25% | 3.73% | 1.75% | 0.00% | 0.00% | 0.45% | 2.11% | 0.37% | 0.00% |
FFTY CapForce IBD 50 ETF | 1.27% | 1.35% | 0.91% | 0.65% | 2.75% | 0.22% | 0.00% | 0.00% | 0.00% | 0.17% |
Frequently Asked Questions
BIS and FFTY have a correlation of -0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIS has higher volatility (12.40%) compared to FFTY (8.45%). In terms of maximum drawdown, BIS dropped -99.89% vs FFTY's -59.46%.
On 10-year performance, FFTY leads with 5.57% vs -24.02% for BIS. On fees, FFTY is cheaper at 0.80% per year. On volatility, FFTY has been the lower-risk option at 8.45%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FFTY has performed better with a 5.57% return vs -24.02%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FFTY is cheaper with a 0.80% expense ratio, compared with 0.95% for BIS.
BIS has the higher dividend yield at 5.61%, compared with 1.27% for FFTY.
BIS is categorized as Leveraged Equities, while FFTY is Mid Cap Growth Equities. BIS tracks NASDAQ Biotechnology Index (-200%), while FFTY tracks IBD 50 Index. They also come from different issuers: ProShares and CapForce. Their fees differ too: 0.95% for BIS and 0.80% for FFTY.
FFTY currently has the higher Sharpe Ratio (0.26 vs -1.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIS and FFTY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer